In the human ovarian cancer cell line SKOV-3, IDO1 is endogenously expressed in a dynamical balance between the holo- and the apo-conformation, depending on the intracellular heme availability and factors stabilizing the protein conformation (19, 33). Here, IDO1 is linked to ovarian carcinoma.